1
|
Fletcher JG, Inoue A, Bratt A, Horst KK, Koo CW, Rajiah PS, Baffour FI, Ko JP, Remy-Jardin M, McCollough CH, Yu L. Photon-counting CT in Thoracic Imaging: Early Clinical Evidence and Incorporation Into Clinical Practice. Radiology 2024; 310:e231986. [PMID: 38501953 DOI: 10.1148/radiol.231986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/20/2024]
Abstract
Photon-counting CT (PCCT) is an emerging advanced CT technology that differs from conventional CT in its ability to directly convert incident x-ray photon energies into electrical signals. The detector design also permits substantial improvements in spatial resolution and radiation dose efficiency and allows for concurrent high-pitch and high-temporal-resolution multienergy imaging. This review summarizes (a) key differences in PCCT image acquisition and image reconstruction compared with conventional CT; (b) early evidence for the clinical benefit of PCCT for high-spatial-resolution diagnostic tasks in thoracic imaging, such as assessment of airway and parenchymal diseases, as well as benefits of high-pitch and multienergy scanning; (c) anticipated radiation dose reduction, depending on the diagnostic task, and increased utility for routine low-dose thoracic CT imaging; (d) adaptations for thoracic imaging in children; (e) potential for further quantitation of thoracic diseases; and (f) limitations and trade-offs. Moreover, important points for conducting and interpreting clinical studies examining the benefit of PCCT relative to conventional CT and integration of PCCT systems into multivendor, multispecialty radiology practices are discussed.
Collapse
Affiliation(s)
- Joel G Fletcher
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| | - Akitoshi Inoue
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| | - Alex Bratt
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| | - Kelly K Horst
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| | - Chi Wan Koo
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| | - Prabhakar Shantha Rajiah
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| | - Francis I Baffour
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| | - Jane P Ko
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| | - Martine Remy-Jardin
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| | - Cynthia H McCollough
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| | - Lifeng Yu
- From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905 (J.G.F., A.I., A.B., K.K.H., C.W.K., P.S.R., F.I.B., C.H.M., L.Y.); Department of Radiology, Shiga University of Medical Science, Shiga, Japan (A.I.); Department of Radiology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (J.P.K.); and IMALLIANCE-Haut-de-France, Valenciennes, France (M.R.J.)
| |
Collapse
|
2
|
Moore J, Remy J, Altschul E, Chusid J, Flohr T, Raoof S, Remy-Jardin M. Thoracic Applications of Spectral CT Scan. Chest 2024; 165:417-430. [PMID: 37619663 DOI: 10.1016/j.chest.2023.07.4225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Revised: 07/29/2023] [Accepted: 07/31/2023] [Indexed: 08/26/2023] Open
Abstract
TOPIC IMPORTANCE Thoracic imaging with CT scan has become an essential component in the evaluation of respiratory and thoracic diseases. Providers have historically used conventional single-energy CT; however, prevalence of dual-energy CT (DECT) is increasing, and as such, it is important for thoracic physicians to recognize the utility and limitations of this technology. REVIEW FINDINGS The technical aspects of DECT are presented, and practical approaches to using DECT are provided. Imaging at multiple energy spectra allows for postprocessing of the data and the possibility of creating multiple distinct image reconstructions based on the clinical question being asked. The data regarding utility of DECT in pulmonary vascular disorders, ventilatory defects, and thoracic oncology are presented. A pictorial essay is provided to give examples of the strengths associated with DECT. SUMMARY DECT has been most heavily studied in chronic thromboembolic pulmonary hypertension; however, it is increasingly being used across a wide spectrum of thoracic diseases. DECT combines morphologic and functional assessments in a single imaging acquisition, providing clinicians with a powerful diagnostic tool. Its role in the evaluation and treatment of thoracic diseases will likely continue to expand in the coming years as clinicians become more experienced with the technology.
Collapse
Affiliation(s)
- Jonathan Moore
- Department of Pulmonary and Critical Care Medicine, Lenox Hill Hospital, Northwell Health Physician Partners, New York, NY
| | - Jacques Remy
- Univ Lille, Department of Thoracic Imaging, Lille, France
| | - Erica Altschul
- Department of Pulmonary and Critical Care Medicine, Lenox Hill Hospital, Northwell Health Physician Partners, New York, NY
| | - Jesse Chusid
- Feinstein Institutes for Medical Research, and Imaging Services, Department of Radiology, Northwell Health, Manhasset, NY
| | - Thomas Flohr
- Department of Computed Tomography Research & Development, Siemens Healthineers, Forchheim, Germany
| | - Suhail Raoof
- Department of Pulmonary and Critical Care Medicine, Lenox Hill Hospital, Northwell Health Physician Partners, New York, NY.
| | - Martine Remy-Jardin
- Univ Lille, Department of Thoracic Imaging, Lille, France; Univ Lille, CHU Lille, Evaluation des technologies de santé et des pratiques médicales, Lille, France
| |
Collapse
|
3
|
Zhan Y, Wang Y, Wang P, Wang Y, Ni X, Wang J, Tang Z. Pretreatment dual-energy CT for predicting early response to induction chemotherapy and survival in nasopharyngeal carcinoma. Eur Radiol 2023; 33:9052-9062. [PMID: 37405505 DOI: 10.1007/s00330-023-09837-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Revised: 04/05/2023] [Accepted: 04/14/2023] [Indexed: 07/06/2023]
Abstract
OBJECTIVES To evaluate the predictive performance of pretreatment dual-energy CT (DECT) for early response to induction chemotherapy and survival in nasopharyngeal carcinoma (NPC). METHODS In this retrospective study, 56 NPC patients who underwent pretreatment DECT scans with posttreatment follow-up were enrolled. The DECT-derived normalised iodine concentration (nIC), effective atomic number (Zeff), 40-180 keV (20 keV interval), and Mix-0.3 value of the tumour lesions were measured to predict the early response to induction chemotherapy and survival in nasopharyngeal carcinoma. The Mann‒Whitney U test, ROC analysis, Kaplan‒Meier method with log-rank test, and Cox proportional hazards model were performed to evaluate the predictive performance of DECT parameters, respectively. RESULTS Among all DECT-derived parameters, ROC analysis showed the predictive performances of nIC and Zeff values for early objective response to induction chemotherapy (AUCs of 0.803 and 0.826), locoregional failure-free survival (AUCs of 0.786 and 0.767), progression-free survival (AUCs of 0.856 and 0.731) and overall survival (AUCs of 0.765 and 0.799) in NPC patients, respectively (all p < 0.05). Moreover, multivariate analysis showed that a high nIC value was an independent predictor of poor survival in NPC. In addition, survival analysis indicated that NPC patients with higher nIC values in primary tumours tend to have lower 5-year locoregional failure-free survival, progression-free survival and overall survival rates than those with lower nIC values. CONCLUSIONS DECT-derived nIC and Zeff values can predict early response to induction chemotherapy and survival in NPC; in particular, a high nIC value is an independent predictive factor of poor survival in NPC. CLINICAL RELEVANCE STATEMENT Preoperative dual-energy computed tomography may provide predictive value for early response and survival outcomes in patients with nasopharyngeal carcinoma, and facilitate their clinical management. KEY POINTS • Pretreatment dual-energy computed tomography helps to predict early response to therapy and survival in NPC. • NIC and Zeff values derived from dual-energy computed tomography can predict early objective response to induction chemotherapy and survival in NPC. • A high nIC value is an independent predictive factor of poor survival in NPC.
Collapse
Affiliation(s)
- Yang Zhan
- Shanghai Institute of Medical Imaging, Fudan University, Shanghai, 200032, China
- Department of Radiology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai, 200031, China
| | - Yuzhe Wang
- Department of Radiology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai, 200031, China
| | - Peng Wang
- Department of Radiology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai, 200031, China
- Department of Radiology, Affiliated Hospital of Jiangnan University, Wuxi, 214122, China
| | - Yin Wang
- Department of Radiology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai, 200031, China
| | - Xiaochen Ni
- Department of Radiation Oncology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
| | - Jie Wang
- Department of Radiation Oncology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
| | - Zuohua Tang
- Department of Radiology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai, 200031, China.
| |
Collapse
|
5
|
Perrella A, Bagnacci G, Di Meglio N, Di Martino V, Mazzei MA. Thoracic Diseases: Technique and Applications of Dual-Energy CT. Diagnostics (Basel) 2023; 13:2440. [PMID: 37510184 PMCID: PMC10378112 DOI: 10.3390/diagnostics13142440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Revised: 07/06/2023] [Accepted: 07/07/2023] [Indexed: 07/30/2023] Open
Abstract
Dual-energy computed tomography (DECT) is one of the most promising technological innovations made in the field of imaging in recent years. Thanks to its ability to provide quantitative and reproducible data, and to improve radiologists' confidence, especially in the less experienced, its applications are increasing in number and variety. In thoracic diseases, DECT is able to provide well-known benefits, although many recent articles have sought to investigate new perspectives. This narrative review aims to provide the reader with an overview of the applications and advantages of DECT in thoracic diseases, focusing on the most recent innovations. The research process was conducted on the databases of Pubmed and Cochrane. The article is organized according to the anatomical district: the review will focus on pleural, lung parenchymal, breast, mediastinal, lymph nodes, vascular and skeletal applications of DECT. In conclusion, considering the new potential applications and the evidence reported in the latest papers, DECT is progressively entering the daily practice of radiologists, and by reading this simple narrative review, every radiologist will know the state of the art of DECT in thoracic diseases.
Collapse
Affiliation(s)
- Armando Perrella
- Unit of Diagnostic Imaging, Department of Medical, Surgical and Neuro Sciences and of Radiological Sciences, University of Siena, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy
| | - Giulio Bagnacci
- Unit of Diagnostic Imaging, Department of Medical, Surgical and Neuro Sciences and of Radiological Sciences, University of Siena, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy
| | - Nunzia Di Meglio
- Unit of Diagnostic Imaging, Department of Medical, Surgical and Neuro Sciences and of Radiological Sciences, University of Siena, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy
| | - Vito Di Martino
- Unit of Diagnostic Imaging, Department of Medical, Surgical and Neuro Sciences and of Radiological Sciences, University of Siena, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy
| | - Maria Antonietta Mazzei
- Unit of Diagnostic Imaging, Department of Medical, Surgical and Neuro Sciences and of Radiological Sciences, University of Siena, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy
| |
Collapse
|
7
|
Zhong F, Chen Y, Chen J, Liao H, Li Y, Ma Y. Jatrorrhizine: A Review of Sources, Pharmacology, Pharmacokinetics and Toxicity. Front Pharmacol 2022; 12:783127. [PMID: 35095493 PMCID: PMC8793695 DOI: 10.3389/fphar.2021.783127] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2021] [Accepted: 12/14/2021] [Indexed: 02/02/2023] Open
Abstract
Jatrorrhizine, an isoquinoline alkaloid, is a bioactive metabolite in common medicinal plants, such as Berberis vernae Schneid., Tinospora sagittata (Oliv.) Gagnep. and Coptis chinensis Franch. These plants have been used for centuries in traditional medicine for their wide-ranging pharmacological properties. This review emphasizes the latest and comprehensive information on the sources, pharmacology, pharmacokinetics and toxicity of jatrorrhizine. Studies on this alkaloid were collected from scientific internet databases, including the Web of Science, PubMed, ScienceDirect, Google Scholar, Elsevier, Springer, Wiley Online Library and Europe PMC and CNKI, using a combination of keywords involving “jatrorrhizine”, “sources”, “pharmacology,” “pharmacokinetics,” and “toxicology”. Jatrorrhizine exhibits anti-diabetic, antimicrobial, antiprotozoal, anticancer, anti-obesity and hypolipidemic properties, along with central nervous system activities and other beneficial activity. Studies of jatrorrhizine have laid the foundation for its application to the treatment of various diseases, but some issues still exist. Further investigations might emphasize 1) specific curative mechanisms of jatrorrhizine and clinical utility, 2) application prospect in the treatment of metabolic disorders, 3) comprehensive investigations of the toxicity mechanisms and 4) interactions of jatrorrhizine with other pharmaceuticals and development of derivatives.
Collapse
Affiliation(s)
- Furong Zhong
- State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu, China.,School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Yang Chen
- State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu, China.,School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Jia Chen
- State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu, China.,School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Hailang Liao
- State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu, China.,School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Yirou Li
- State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu, China.,School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Yuntong Ma
- State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu, China.,School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| |
Collapse
|